Beta-2-adrenergic receptor polymorphisms and changes in lipids induced by metoprolol

Pharmacology

Volumn 80, Issue 4, 2007, Pages 279-285

  Isaza, Carlos A ^a   Henao, Julieta ^a   Sánchez, Julio C ^a   Porras, Gloria L ^a,b   Cardona, J ^b   Bedoya, G ^b  

^a UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

^b ESE Salud Pereira   (Colombia)

Author keywords

2 receptor; Adrenoceptors; Polymorphism

Indexed keywords

ANTILIPEMIC AGENT; ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUTAMINE; GLYCINE; LIPID; METOPROLOL;

ADULT; AGED; ALLELE; ARTICLE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CODON; DEMOGRAPHY; DIETARY INTAKE; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; FEMALE; GENOTYPE; HUMANS; LIPIDS; MALE; METOPROLOL; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2;

EID: 35048860060     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106554     Document Type: Article

References (49)

1. Westfall TC, Westfall DP: Adrenergic agonists and antagonists; in Brunton L, Lazo J, Parker K (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, McGraw-Hill, 2006, vol 1, pp 237-295.
2. Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon RA, Keller P, Caron MG, Lefkowitz RJ: Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem 1987;262:7321-7327.
3. Liggett SB: Beta(2)-adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med 2000;161:S197-S201.
4. Kato N, Sugiyama T, Morita H, Kurihara H, Sato T, Yamori Y, Yazaki Y: Association analysis of beta(2)-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 2001;37:286-292.
5. Ranade K, Shue WH, Hung YJ, Hsuing CA, Chiang FT, Pesich R, Hebert J, Olivier M, Chen YD, Pratt R, Olshen R, Curb D, Botstein D, Risch N, Cox DR: The glycine allele of a glycine/arginine polymorphism in the beta2-adrenergic receptor gene is associated with essential hypertension in a population of Chinese origin. Am J Hypertens 2001;14:1196-1200.
6. Pereira AC, Floriano MS, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, Krieger JE: Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 2003;42:685-692.
7. Kaye DM, Smirk B, Williams C, Jennings G, Esler M, Holst D: Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics 2003;13:379-382.
8. Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, Abraham WT, Chenier TC, Dorn GW 2nd, Liggett SB: Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 2000;86:834-840.
9. Kaye DM, Smirk B, Finch S, Williams C, Esler MD: Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype. J Am Coll Cardiol 2004;44:2008-2015.
10. Barbato E, Berger A, Delrue L, Van Durme F, Manoharan G, Boussy T, Heyndrickx GR, De Bruyne B, Ciampi Q, Vanderheyden M, Wijns W, Bartunek J: GLU-27 variant of beta2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease. Atherosclerosis 2006; Epub ahead of print.
11. Sotoodehnia N, Siscovick DS, Vatta M, Psaty BM, Tracy RP, Towbin JA, Lemaitre RN, Rea TD, Durda JP, Chang JM, Lumley TS, Kuller LH, Burke GL, Heckbert SR: Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation 2006;113:1842-1848.
12. Kaza V, Bandi V, Guntupalli KK: Acute severe asthma: recent advances. Curr Opin Pulm Med 2007;13:1-7.
13. Litonjua AA, Silverman EK, Tantisira KG, Sparrow D, Sylvia JS, Weiss ST: Beta 2-adrenergic receptor polymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men. Chest 2004;126:66-74.
14. Matheson MC, Ellis JA, Raven J, Johns DP, Walters EH, Abramson MJ: Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. J Hum Genet 2006;51:943-951.
15. Turner SW, Khoo SK, Laing IA, Palmer LJ, Gibson NA, Rye P, Landau LI, Goldblatt J, Le Souef PN: beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children. Clin Exp Allergy 2004;34:1043-1048.
16. Wjst M: Beta2-adrenoreceptor polymorphisms and asthma. Lancet 2006;368:710-711.
17. Dallongeville J, Helbecque N, Cottel D, Amouyel P, Meirhaeghe A: The Gly16-> Arg16 and Gln27->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 2003;88:4862-4866.
18. Ehrenborg E, Skogsberg J, Ruotolo G, Large V, Eriksson P, Arner P, Hamsten A: The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. J Intern Med 2000;247:651-656.
19. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, Arner P: Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997;100:3005-3013.
20. Masuo K, Katsuya T, Kawaguchi H, Fu Y, Rakugi H, Ogihara T, Tuck ML: Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. Am J Hypertens 2006;19:1084-1091.
21. Wessel J, Moratorio G, Rao F, Mahata M, Zhang L, Greene W, Rana BK, Kennedy BP, Khandrika S, Huang P, Lillie EO, Shih PA, Smith DW, Wen G, Hamilton BA, Ziegler MG, Witztum JL, Schork NJ, Schmid-Schonbein GW, O'Connor DT: C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta- adrenergic pathway loci. J Hypertens 2007;25:329-343.
22. Chong LK, Chowdry J, Ghahramani P, Peachell PT: Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 2000;10:153-162.
23. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ: The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001;345:1030-1035.
24. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe MR, Skrabal F: beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999;33:1425-1430.
25. Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB: beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 2000;139:537-542.
26. Candy G, Samani N, Norton G, Woodiwiss A, Radevski I, Wheatley A, Cockcroft J, Hall IP: Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 2000;18:167-172.
27. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB: Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000;97:10483-10488.
28. Leineweber K, Brodde OE: Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes. Life Sci 2004;74:2803-2814.
29. Shin J, Lobmeyer MT, Gong Y, Zineh I, Langaee TY, Yarandi H, Schofield RS, Aranda JM Jr, Hill JA, Pauly DF, Johnson JA: Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. Am J Cardiol 2007;99:250-255.
30. Meirhaeghe A, Luan J, Selberg-Franks P, Hennings S, Mitchell J, Halsall D, O'Rahilly S, Wareham NJ: The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity. J Clin Endocrinol Metab 2001;86:5881-5887.
31. Arner P: Obesity - a genetic disease of adipose tissue? Br J Nutr 2000;83(suppl 1):S9-S16.
32. Carlsson M, Orho-Melander M, Hedenbro J, Groop LC: Common variants in the beta2-(Gln27Glu) and beta3-(Trp64Arg)-adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes. Diabetologia 2001;44:629-636.
33. Gjesing AP, Andersen G, Burgdorf KS, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O: Studies of the associations between functional beta(2)-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Diabetologia 2007;50:563-568.
34. Rosmond R, Ukkola O, Chagnon M, Bouchard C, Bjorntorp P: Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med 2000;248:239-244.
35. Ukkola O, Tremblay A, Bouchard C: Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. Int J Obes Relat Metab Disord 2001;25:1604-1608.
36. Kurtz TW: New treatment strategies for patients with hypertension and insulin resistance. Am J Med 2006;119:S24-S30.
37. Iaccarino G, Trimarco V, Lanni F, Cipolletta E, Izzo R, Arcucci O, De Luca N, Di Renzo G: beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene. Pharmacogenomics J 2005;5:292-297.
38. Isaza C, Henao J, Ramirez E, Cuesta F, Cacabelos R: Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population. Methods Find Exp Clin Pharmacol 2005;27:237-244.
39. Bernat M, Titos E, Claria J: Rapid identification of single nucleotide polymorphisms by fluorescence-based capillary electrophoresis. Genet Mol Res 2002;1:72-78.
40. Tanigawara Y, Kita T, Hirono M, Sakaeda T, Komada F, Okumura K: Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood. Ther Drug Monit 2001;23:341-346.
41. Eriksson P, Dahlman I, Ryden M, Hoffstedt J, Arner P: Relationship between beta-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women. Int J Obes Relat Metab Disord 2004;28:185-190.
42. Ikarashi T, Hanyu O, Maruyama S, Souda S, Kobayashi C, Abe E, Ukisu J, Naganuma K, Suzuki A, Toya M, Kaneko S, Suzuki K, Nakagawa O, Aizawa Y: Genotype Gly/Gly of the Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with elevated fasting serum insulin concentrations, but not with acute insulin response to glucose, in type 2 diabetic patients. Diabetes Res Clin Pract 2004;63:11-18.
43. Lima JJ, Matsushima N, Kissoon N, Wang J, Sylvester JE, Jusko WJ: Modeling the metabolic effects of terbutaline in beta2-adrenergic receptor diplotypes. Clin Pharmacol Ther 2004;76:27-37.
44. Ochoa Mdel C, Marti A, Martinez JA: Obesity studies in candidate genes (in Spanish). Med Clin (Barc) 2004;122:542-551.
45. Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lusardi P: Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol 1999;33:534-539.
46. Weir MR, Moser M: Diuretics and beta-blockers: is there a risk for dyslipidemia? Am Heart J 2000;139:174-183.
47. Iaccarino G, Lanni F, Cipolletta E, Trimarco V, Izzo R, Iovino GL, De Luca N, Trimarco B: The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. J Hypertens 2004;22:2117-2122.
48. Iwamoto N, Ogawa Y, Kajihara S, Hisatomi A, Yasutake T, Yoshimura T, Mizuta T, Hara T, Ozaki I, Yamamoto K: Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver. Clin Chim Acta 2001;314:85-91.
49. Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F: Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res 2002;30:3295-3311.